Retraction of: Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation (Stroke (1997) 28 (736-739) DOI: 10.1161/01.STR.28.4.736);Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1α-hydroxyvitamin D3 and calcium supplementation

Stroke

Volumn 28, Issue 4, 1997, Pages 736-739

  Sato, Yoshihiro ^a   Maruoka, Hiroshi ^a   Oizumi, Kotaro ^b  

^a Futase Social Insurance Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

calcium; complications; hemiplegia; osteoporosis; vitamin D

Indexed keywords

ALFACALCIDOL; CALCIUM;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEMIPLEGIA; HIP FRACTURE; HUMAN; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STROKE;

EID: 0030891033     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STR.0000000000000187     Document Type: Erratum

References (23)

1. Peszczynski M. The fractured hip in hemiplegic patients. Geriatrics. 1957;12:687-690.
2. Mulley G, Espley AJ. Hip fracture after hemiplegia. Postgrad Med J. 1979;55:264-265.
3. Poplingher AR, Pillar T. Hip fracture in stroke patients. Acta Orthop Scand. 1985;56:226-227.
4. Hooper G. Internal fixation of fractures of the neck of the femur in hemiplegic patients. Injury. 1979;10:281-284.
5. Chiu KY, Pun WK, Luk KDK, Chow SP. A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury. 1992;23:297-299.
6. Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K. Development of osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol. 1996;36:278-283.
7. Sato Y, Maruoka H, Oizumi K, Kikuyama M. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke. 1996;27:2183-2187.
8. Shiraki M, Ito H, Orimo H. The ultra long-term treatment of senile osteoporosis with 1α-hydroxyvitamin D3. Bone Miner. 1993;20: 223-234.
9. Shiraki M. Treatment of osteoporosis with vitamin D3. Osteoporosis Int. 1993;1(suppl):176-180.
10. Menczel J, Foldes J, Steinberg R, Leichter I, Shalita B, Bdolah-Abram T, Kadosh S, Mazor Z, Ladkani D. Alfacalcidol (alpha D3) and calcium in osteoporosis. Clin Orthop Rel Res. 1994; 300:241-247.
11. Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N. Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int. 1994: 54;370-376.
12. Orimo H, Shiraki M, Hayashi T, Nakamura T. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with la(OH)-vitamin D3. Bone Miner. 1987;3:47-52.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md St Med J. 1965;14:61-65.
14. Brunstrom S. Motor testing procedures in hemiplegia based on sequential recovery stages. Am J Phys Ther. 1966:46;357-375.
15. Special Report From the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637-676.
16. Inoue T, Orimo H, Koshikawa S, Ross PD, Gallagher JC, Kanis JA. Acronym of improved microdensitometry (computed x-ray densitometry). J Bone Miner Met. 1994;12:145. Letter.
17. Mastumoto C, Kushida K, Yamazaki K, Imose K, Inoue T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed x-ray densitometry. Calcif Tissue Int. 1994;55: 324-329.
18. Orimo H, Inoue T, Fujita T, Itami V. Clinical experience with 1α-OH-D3: senile osteoporosis. In: Norman AW, Schaefer K, Herrath DV, Grigoleit HG, eds. Vitamin D: Chemical, Biochemical and Clinical Endocrinology of Ca Metabolism. Berlin, Germany: Walter de Gruyter; 1982:1239-1243.
19. Pouilles JM, Tremollieres F, Todorovsky N, Ribot C. Precision and sensitivity of dual-energy x-ray absorptiometry in spinal osteoporosis. J Bone Miner Res. 1991;6:997-1002.
20. Chapuy MC, Arlot ME, Duboeuf FD, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327:1637-1642.
21. Storm T, Steiniche T, Thamsborg G, Meisen F. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res. 1993;8:199-208.
22. Katsumata T, Nakamura T, Ohnishi H, Sakurama T. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Miner Res. 1995;10:921-931.
23. Storm T, Thamsborg G, Steiniche T, Genant HK, Sørensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990;322:1265-1271.